Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis.

@article{Garca2000SingledoseA,
  title={Single-dose AmBisome (Liposomal amphotericin B) as prophylaxis for murine systemic candidiasis and histoplasmosis.},
  author={Ada Garc{\'i}a and Jill P. Adler-Moore and Richard T Proffitt},
  journal={Antimicrobial agents and chemotherapy},
  year={2000},
  volume={44 9},
  pages={2327-32}
}
AmBisome is a liposomal formulation of amphotericin B that has broad-spectrum antifungal activity and greatly reduced toxicity compared to the parent drug. In this study, amphotericin B deoxycholate (Fungizone) (1 mg/kg) and AmBisome (1 to 20 mg/kg) were tested as single-dose prophylactic agents in both immunocompetent and immunosuppressed C57BL/6 mice challenged with either Candida albicans or Histoplasma capsulatum. Prophylactic efficacy was based on survival and fungal burden in the target… CONTINUE READING
14 Citations
42 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 14 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

AmBisome: a developmental case study of a liposomal formulation of the antifungal agent amphotericin B

  • J. P. Adler-Moore, R. T. Proffitt
  • 2000
1 Excerpt

Different effects of granulocyte colonystimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice

  • A. M. Buisman, T. L. Van Zwet, J. A. Langermans, M. F. Geertsma, P. J. Leenen, R. van Furth
  • Immunology
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…